Evidence map›Paper›PMID 35325447›Full record

ArticleJournal of endocrinological investigation2022

Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic.

M Žarković, P Perros, J Ćirić, B Beleslin, M Stojanović, M Stojković, M Miletić, T Janić

Abstract read
In one paragraph

Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M ŽarkovićFaculty of Medicine, University of Belgrade, Belgrade, Serbia. milos.zarkovic@med.bg.ac.rs.ORCID http://orcid.org/0000-0001-9977-5970
P PerrosDepartment of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0001-7320-5574
J ĆirićFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
B BeleslinFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
M StojanovićFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
M StojkovićFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
M MiletićFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
T JanićClinic of Endocrinology, Diabetes and Diseases of Metabolism, University Clinical Centre, Dr Subotića starijeg 13, 11000, Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care.

methodsThis study consisted of a web-based survey. The survey was anonymous and consisted of forty questions.

resultsThis survey included 206 respondents. 91.3% of the respondents had health insurance through the Republic Fund of Health Insurance, 9.7% had private or both health insurances, and 3.4% did not have any health insurance. A significant proportion of respondents (60.4%) had to switch from public to private health care to reach a physician and 73.8% had to switch from public to private laboratories. For the 91.9%, this was perceived as a financial burden. Before the pandemic, 83.1% of respondents reported regular follow-up by physicians, which decreased to 44.9% during the pandemic (p < 0.01). 76.3% of the respondents regarded that their thyroid disease was managed optimally before the pandemic, while this figure declined to only 48% during the pandemic (p < 0.01).

conclusionsThe COVID-19 pandemic disrupted the medical care of thyroid patients in Serbia. For the patients treated in the public health care system, access to general practice was hindered, while access to specialist care was disrupted. It led to a switch from public to private health care, which was perceived as a financial burden for almost all the respondents. However, private health care proved to be an important safety net when the public system was overwhelmed.

Indexed as

COVID-19Thyroid DiseasesHealth Services AccessibilityHumansPandemicsSerbiaSurveys and QuestionnairesCOVID-19Health carePandemicSerbiaThyroid

Identifiers

PMID35325447
PMCPMC8944403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.